In PT practice, how is evidence used to determine the strength of a treatment recommendation?

In PT practice, how is evidence used to determine the strength of a treatment recommendation?

• A. By applying the evidence hierarchy to weigh study design and quality.
• B. By selecting the most interesting study to the clinician.
• C. By asking the patient to decide without discussing evidence.
• D. By using only pathophysiology knowledge without evidence.

Answer: (A)

Evidence-based practice in physical therapy relies on a structured way to judge how strongly we should recommend a treatment. The strength of a recommendation comes from applying an evidence hierarchy that weighs study design and quality. Higher-quality designs, like randomized controlled trials and systematic reviews, provide more reliable information about a treatment’s effects, while lower-quality designs offer weaker evidence. We also consider how consistent the findings are across studies, how directly they apply to the patient population, the precision of the effect estimates, and the risk of bias in the studies. When multiple high-quality studies show consistent, direct, and precise benefits, we can give a strong recommendation. If the evidence is limited, inconsistent, or biased, the recommendation is weaker and may call for shared decision-making with the patient and consideration of values and preferences. Choosing the most interesting study, asking the patient to decide without discussing evidence, or relying solely on pathophysiology knowledge without evidence do not provide a sound basis for strength of recommendation, because they ignore the actual clinical outcomes and the quality of the data behind those outcomes.

Evidence-based practice in physical therapy relies on a structured way to judge how strongly we should recommend a treatment. The strength of a recommendation comes from applying an evidence hierarchy that weighs study design and quality. Higher-quality designs, like randomized controlled trials and systematic reviews, provide more reliable information about a treatment’s effects, while lower-quality designs offer weaker evidence. We also consider how consistent the findings are across studies, how directly they apply to the patient population, the precision of the effect estimates, and the risk of bias in the studies. When multiple high-quality studies show consistent, direct, and precise benefits, we can give a strong recommendation. If the evidence is limited, inconsistent, or biased, the recommendation is weaker and may call for shared decision-making with the patient and consideration of values and preferences.

Choosing the most interesting study, asking the patient to decide without discussing evidence, or relying solely on pathophysiology knowledge without evidence do not provide a sound basis for strength of recommendation, because they ignore the actual clinical outcomes and the quality of the data behind those outcomes.